1-month safety results in a randomized controlled trial (COATING) evaluating a surface-modification flow diverter (p64-MW-HPC) under single antiplatelet treatment.
Pierot L, Eker OF, Henkes H, Psychogios MN, Cohen J, Lamin S, Pedowski P, Gentric JC, Ciceri E, Holtmannspoetter M, Cognard C, Tsogkas I, Khanafer A, Marnat G, Riva R, Cortese J, Soize S, Willems T, Barreau X, Spelle L